Stewart Abbot
2016
In 2016, Stewart Abbot earned a total compensation of $736.6K as Chief Development Officer at Fate Therapeutics, a 28% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $77,350 |
|---|---|
| Option Awards | $295,800 |
| Salary | $340,000 |
| Other | $23,424 |
| Total | $736,574 |
Abbot received $340K in salary, accounting for 46% of the total pay in 2016.
Abbot also received $77.4K in non-equity incentive plan, $295.8K in option awards and $23.4K in other compensation.
Rankings
In 2016, Stewart Abbot's compensation ranked 9,663rd out of 14,075 executives tracked by ExecPay. In other words, Abbot earned more than 31.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,663 out of 14,075 | 31st |
Division Manufacturing | 3,746 out of 5,489 | 32nd |
Major group Chemicals And Allied Products | 1,303 out of 1,895 | 31st |
Industry group Drugs | 1,036 out of 1,538 | 33rd |
Industry Biological Products, Except Diagnostic Substances | 181 out of 279 | 35th |
Source: SEC filing on March 22, 2017.
Abbot's colleagues
We found two more compensation records of executives who worked with Stewart Abbot at Fate Therapeutics in 2016.